Warning: The NCBI web site requires JavaScript to function. more...
Factors related to compliance to anti-malarial drug combination: example of amodiaquine/sulphadoxine-pyrimethamine among children in rural Senegal.
Souares A, Lalou R, Sene I, Sow D, Le Hesran JY.
Malar J. 2009 Jun 4;8:118.
Related citations
Self-reported data: a major tool to assess compliance with anti-malarial combination therapy among children in Senegal.
Souares A, Moulin P, Sarrassat S, Carlotti MP, Lalou R, Le Hesran JY.
Malar J. 2009 Nov 17;8:257.
Adherence and effectiveness of drug combination in curative treatment among children suffering uncomplicated malaria in rural Senegal.
Trans R Soc Trop Med Hyg. 2008 Aug;102(8):751-8.
Child age or weight: difficulties related to the prescription of the right dosage of antimalarial combinations to treat children in Senegal.
Souares A, Lalou R, Senghor P, Le Hesran JY.
Trans R Soc Trop Med Hyg. 2010 Feb;104(2):104-9. Epub 2009 Aug 27.
Artemisinin-based combinations versus amodiaquine plus sulphadoxine-pyrimethamine for the treatment of uncomplicated malaria in Faladje, Mali.
Kayentao K, Maiga H, Newman RD, McMorrow ML, Hoppe A, Yattara O, Traore H, Kone Y, Guirou EA, Saye R, Traore B, Djimde A, Doumbo OK.
Malar J. 2009 Jan 7;8:5.
Efficacy of chloroquine, amodiaquine, sulfadoxine-pyrimethamine, chloroquine-sulfadoxine-pyrimethamine combination, and amodiaquine-sulfadoxine-pyrimethamine combination in Central African children with noncomplicated malaria.
Menard D, Madji N, Manirakiza A, Djalle D, Koula MR, Talarmin A.
Am J Trop Med Hyg. 2005 May;72(5):581-5.
Low efficacy of amodiaquine or chloroquine plus sulfadoxine-pyrimethamine against Plasmodium falciparum and P. vivax malaria in Papua New Guinea.
Marfurt J, Müeller I, Sie A, Maku P, Goroti M, Reeder JC, Beck HP, Genton B.
Am J Trop Med Hyg. 2007 Nov;77(5):947-54.
Artesunate + amodiaquine and artesunate + sulphadoxine-pyrimethamine for treatment of uncomplicated malaria in Democratic Republic of Congo: a clinical trial with determination of sulphadoxine and pyrimethamine-resistant haplotypes.
Swarthout TD, van den Broek IV, Kayembe G, Montgomery J, Pota H, Roper C.
Trop Med Int Health. 2006 Oct;11(10):1503-11.
Improved efficacy with amodiaquine instead of chloroquine in sulfadoxine/pyrimethamine combination treatment of falciparum malaria in Uganda: experience with fixed-dose formulation.
Obua C, Gustafsson LL, Aguttu C, Anokbonggo WW, Ogwal-Okeng JW, Chiria J, Hellgren U.
Acta Trop. 2006 Nov;100(1-2):142-50. Epub 2006 Nov 20.
Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.
Tekete M, Djimde AA, Beavogui AH, Maiga H, Sagara I, Fofana B, Ouologuem D, Dama S, Kone A, Dembele D, Wele M, Dicko A, Doumbo OK.
Malar J. 2009 Feb 26;8:34.
Amodiaquine dosage and tolerability for intermittent preventive treatment to prevent malaria in children.
Cairns M, Cisse B, Sokhna C, Cames C, Simondon K, Ba EH, Trape JF, Gaye O, Greenwood BM, Milligan PJ.
Antimicrob Agents Chemother. 2010 Mar;54(3):1265-74. Epub 2010 Jan 11.
Randomized trial of piperaquine with sulfadoxine-pyrimethamine or dihydroartemisinin for malaria intermittent preventive treatment in children.
Cisse B, Cairns M, Faye E, NDiaye O, Faye B, Cames C, Cheng Y, NDiaye M, Lô AC, Simondon K, Trape JF, Faye O, NDiaye JL, Gaye O, Greenwood B, Milligan P.
PLoS One. 2009 Sep 28;4(9):e7164.
Pattern of drug utilization for treatment of uncomplicated malaria in urban Ghana following national treatment policy change to artemisinin-combination therapy.
Dodoo AN, Fogg C, Asiimwe A, Nartey ET, Kodua A, Tenkorang O, Ofori-Adjei D.
Malar J. 2009 Jan 5;8:2.
Chloroquine resistant Plasmodium falciparum malaria in Osogbo Nigeria: efficacy of amodiaquine + sulfadoxine-pyrimethamine and chloroquine + chlorpheniramine for treatment.
Ogungbamigbe TO, Ojurongbe O, Ogunro PS, Okanlawon BM, Kolawole SO.
Mem Inst Oswaldo Cruz. 2008 Feb;103(1):79-84.
Comparison of the parasitologic efficacy of amodiaquine and sulfadoxine-pyrimethamine in the treatment of Plasmodium falciparum malaria in the Bungoma District of western Kenya.
Vreugdenhil CJ, Scheper FY, Hoogstraatte SR, Smolders M, Gikunda S, Cobelens FG, Kager PA.
Am J Trop Med Hyg. 2004 Nov;71(5):537-41.
Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda.
Yeka A, Banek K, Bakyaita N, Staedke SG, Kamya MR, Talisuna A, Kironde F, Nsobya SL, Kilian A, Slater M, Reingold A, Rosenthal PJ, Wabwire-Mangen F, Dorsey G.
PLoS Med. 2005 Jul;2(7):e190. Epub 2005 Jul 26.
How sulfadoxine-pyrimethamine (SP) was perceived in some rural communities after phasing out chloroquine (CQ) as a first-line drug for uncomplicated malaria in Tanzania: lessons to learn towards moving from monotherapy to fixed combination therapy.
Nsimba SE.
J Ethnobiol Ethnomed. 2006 Jan 10;2:5.
Sulphadoxine/pyrimethamine versus amodiaquine for treating uncomplicated childhood malaria in Gabon: a randomized trial to guide national policy.
Nsimba B, Guiyedi V, Mabika-Mamfoumbi M, Mourou-Mbina JR, Ngoungou E, Bouyou-Akotet M, Loembet R, Durand R, Le Bras J, Kombila M.
Malar J. 2008 Feb 12;7:31.
Anti-malarial prescriptions in three health care facilities after the emergence of chloroquine resistance in Niakhar, Senegal (1992-2004).
Munier A, Diallo A, Cot M, Ndiaye O, Arduin P, Chippaux JP.
Malar J. 2009 Apr 27;8:83.
Management of uncomplicated malaria in children under 13 years of age at a district hospital in Senegal: from official guidelines to usual practices.
Sarrassat S, Lalou R, Cissé M, Le Hesran JY.
Malar J. 2011 Sep 29;10:285.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on